ASX Announcements

31 August 2020

Preliminary Final Report

The Preliminary Final Report (Appendix 4E) on the financial results for the year ended 30 June 2020 was released today.

The COVID-19 pandemic affected progress in the company’s ongoing projects as well as opportunities to progress licensing and partnership discussions, particularly during the second half of the year. This is r...

21 August 2020

LCT Founder Sir Robert Elliott Dies

Living Cell Technologies (LCT) founder, Emeritus Professor Sir Robert Elliott, has died aged 86.

Chairman Dr Bernie Tuch today paid tribute to one of the country’s foremost scientific entrepreneurs.

“The medical, scientific and biotechnology communities in New Zealand have lost a tireless researcher and a visionary p...

31 July 2020

Appendix 4C - AMENDED June Quarter

In the Appendix 4C lodged 30 July 2020 the values represented in the current quarter and year to date columns are not valued in $A’000. The corresponding numbers in the attached amended Appendix 4C have not changed from those released at 10:10am AEST on 30 July 2020.

LCT ended the June quarter with a cash balance of ...

30 July 2020

Appendix 4C June quarter

LCT ended the June quarter with a cash balance of $2,964,873 compared to $3,633,042 in the previous quarter.

Net operating cash flow in the quarter was $(841,919) compared to $140,454 in the previous quarter. Receipts from grants and tax incentives were $40,873 (previous quarter $648,733).

Operating payments were $909,54...

13 July 2020

Response to Aware Query

LCT refers to ASX’s letter of 6 July 2020 and confirms that as outlined in our email to you also of 6 July, the only new information contained in the Company’s Newsletter released to ASX on 3 July related to the reopening of the University labs – specifically the Newsletter stated “The team at the University of Auckland has resume...